Sorted By:

Relevance


Medicare Monday: Who qualifies for Part D Extra Help?

PhRMA  |  Blog Post

(Click here for Diane’s full profile.)
http://catalyst.phrma.org/catalyst-dev/medicare-monday-who-qualifies-for-part-d-extra-help-0

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/catalyst-dev/new-report-highlights-more-than-250-vaccines-in-development-0

Las Compañías Biofarmacéuticas de Estados Unidos Lanzan una Innovadora Iniciativa Anunciando la Nueva Era de la Medicina

PhRMA  |  Press Release

Desde el año 2000, las empresas miembros de PhRMA han invertido más de medio trillón de dólares en la búsqueda de nuevos tratamientos y curas, incluyendo un estimado de $58.8 mil millones en el año 2015 por sí solo.
http://www.phrma.org/press-release/las-compa-as-biofarmac-uticas-de-estados-unidos-lanzan-una-innovadora-iniciativa-anunciando-la-nueva-era-de-la-medicina

PhRMA Statement on Support of DEA National Take Back Day

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-on-support-of-dea-national-take-back-day

CEF

PhRMA  |  Company

...
http://www.phrma.org/company/cef

Ken Frazier

PhRMA  |  Biography

Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.
http://www.phrma.org/biography/ken-frazier

Rare Disease Day: Accelerating innovation for patients in need

PhRMA  |  Blog Post

Learn more about progress in rare disease research here.
http://catalyst.phrma.org/rare-disease-day-accelerating-innovation-for-patients-in-need

World AIDS Day 2016: A decade of scientific innovation

PhRMA  |  Blog Post

Currently, 33 vaccine candidates are in clinical development, offering tremendous hope for a future without HIV/AIDS.
http://catalyst.phrma.org/world-aids-day-2016-a-decade-of-scientific-innovation

Celebrating hope for patients and families on World Heart Day 2016

PhRMA  |  Blog Post

World Heart Day is a reminder that innovation helps reduce the impact of heart disease on patients and families.
http://catalyst.phrma.org/celebrating-hope-for-patients-and-families-on-world-heart-day-2016

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

PhRMA  |  Blog Post

Any discussion about value must include recognition of the shared responsibility to make sure patients actually get the medicines they need.
http://catalyst.phrma.org/phrma-ceo-in-forbes-how-to-negotiate-better-deals-for-prescription-medicines

Medicare Monday: 3 reasons why repealing Part D’s noninterference clause is a bad idea

PhRMA  |  Blog Post

It’s important to find ways to build on Part D’s success, not undermine a program that over 40 million beneficiaries rely on for access to medicines.
http://catalyst.phrma.org/medicare-monday-3-reasons-why-repealing-part-ds-noninterference-clause-is-a-bad-idea

Un informe describe diversos medicamentos nuevos en desarrollo para combatir la epidemia de diabetes que afecta a más de 30 millones de estadounidenses

PhRMA  |  Press Release

Conéctese con PhRMAPara obtener información sobre cómo salvan vidas los medicamentos innovadores, por favor visite: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/medicamentos-en-desarrollo-para-la-diabetes

Reauthorize the Prescription Drug User Fee Act

PhRMA  |  Graphic

Reauthorization of the Prescription Drug, Biosimilar and Generic Drug User Fee Acts is crucial to ensuring innovative new medicines continue to reach patients in need.
http://www.phrma.org/graphic/reauthorize-the-prescription-drug-user-fee-act

Medicare Monday: Did you know … ?

PhRMA  |  Blog Post

For more videos on Part D, click .youtube.com/playlist?
http://catalyst.phrma.org/medicare-monday-did-you-know

Video: PhRMA CEO discusses medicine costs with CNBC's Squawk Box

PhRMA  |  Blog Post

Visit PhRMA.org/LetsTalkCost to learn more.
http://catalyst.phrma.org/video-phrma-ceo-discusses-medicine-costs-with-cnbcs-squawk-box

Video: Translating science into new medicines

PhRMA  |  Blog Post

His personal experiences helping his father with diabetes and later his mother with metastatic breast cancer helped shape his passion for researching new treatments.
http://catalyst.phrma.org/video-translating-science-into-new-medicines

Using setbacks as stepping stones in Alzheimer’s research

PhRMA  |  Blog Post

The Alzheimer’s community is watching these trials closely and the many others taking new approaches to fight this terrible disease.
http://catalyst.phrma.org/catalyst-dev/the-science-of-hope-using-setbacks-as-stepping-stones-in-alzheimers-research-0

ICYMI: New era of medicine initiative kicks off in Boston

PhRMA  |  Blog Post

Ubl provides underwriter perspective on new era of medicine happening in science.
http://catalyst.phrma.org/icymi-new-era-of-medicine-initiative-kicks-off-in-boston

Medicare Monday: Who qualifies for Part D Extra Help?

PhRMA  |  Blog Post

(Click here for Diane’s full profile.)
http://catalyst.phrma.org/medicare-monday-who-qualifies-for-part-d-extra-help

Medicare Monday: Kicking off 2017 with Medicare resources

PhRMA  |  Blog Post

Be sure to subscribe to the Catalyst.
http://catalyst.phrma.org/medicare-monday-kicking-off-2017-with-medicare-resources

PhRMA Lanza Nuevos Recursos del Cuidado de la Salud en Español

Access Better Coverage  |  From Our Network

Para obtener más recursos, visite www.AccessBetterCoverage.org/espanol.
http://www.accessbettercoverage.org/social-news/phrma-lanza-nuevos-recursos-del-cuidado-de-la-salud-en-espanol

Nuevos Informes Destacan el Aumento de la Competencia Global en I + D Biofarmacéutica, Planteando Desafíos Significativos para la Futura Posición de Estados Unidos

PhRMA  |  Press Release

Conectar con PhRMA Para obtener información sobre cómo los medicamentos innovadores salvan vidas, por favor visite: www.PhRMA.org .innovation.org/?
http://www.phrma.org

Statement on Biosimilar User Fee Act Reauthorization

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/statement-on-biosimilar-user-fee-act-reauthorization1

Las Compañías Miembros de PhRMA Invirtieron $58,8 Billones en I&D en 2015

PhRMA  |  Press Release

  Conectar con PhRMA Para obtener información sobre cómo los medicamentos innovadores salvan vidas, por favor visite:   www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/las-compa-as-miembros-de-phrma-invirtieron-58-8-billones-en-iandd-en-2015

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Create a new safe harbor to the AKS to protect value-based arrangements and provide clarity for companies.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

You have reviewed the first 25 results out of 2024. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next